New results from the GLOW trial show Gelesis’ Gelesis100 superabsorbent hydrogel can reduce insulin resistance in overweight and obese patients, independent of their starting weight.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?